Masaki Fukunaga

Mr. Masaki Fukunaga

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YNYUKI NARITA
YUKI NARITA
KFKoichi Fukumoto
Koichi Fukumoto
MFMasaki Fukunaga
Masaki Fukunaga
YKYuki Kondo
Yuki Kondo
YIYoichi Ishitsuka
Yoichi Ishitsuka
SHSumio Hirata
Sumio Hirata
Patients on dialysis are frequently administered high doses of potassium binders such as calcium polystyrene sulfonate (CPS) and sodium polystyrene sulfonate (SPS), which exacerbate constipation. Here, we compare the degree of constipation induced by CPS and SPS using a loperamide-induced constipation model to identify the safer potassium binder. Constipation model was created by twice-daily intraperitoneal administration (ip) of loperamide hydrochloride (Lop; 1 mg/kg body weight) in rats for 3 days. Rats were assigned to a control group, Lop group, Lop + CPS group or Lop + SPS group, and a crossover comparative study was performed. Defecation status (number of feces, feces wet weight, fecal water content and gastrointestinal transit time (GTT)) was evaluated. In the Lop + CPS group, GTT was significantly longer, and fecal water content was reduced. In the Lop + SPS group—although the fecal water content and GTT were unaffected—the number of fecal pellets and the fecal wet weight improved. Thus, SPS was less likely to cause constipation exacerbation than CPS. Considering the high frequency of constipation in dialysis patients with hyperkalemia, preferentially administering SPS over CPS may prevent constipation exacerbation.

12 June 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MFMasaki Fukunaga
Masaki Fukunaga
DKDaisuke Kadowaki
Daisuke Kadowaki
MMMika Mori
Mika Mori
SHSatomi Hagiwara
Satomi Hagiwara
YNYUKI NARITA
YUKI NARITA
SHSumio Hirata
Sumio Hirata
It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate drug removal by utilizing a rat model of HD (HD rat) and to extrapolate this result to the drug removal rate in HD patients. HD rats received bilateral nephrectomy and HD for 2 h. The dialysis removal of 6 drugs was evaluated in HD rats. Dialysis efficiency, plasma protein binding rate (PBR) and distribution volume (Vd) of drugs were also measured. Furthermore, we examined the correlation between the dialyzability of drug in HD rats and humans and constructed the prediction formula of the drug dialyzability in HD patients. The clearance of urea and creatinine and normalized dialysis dose in HD rats were 0.83 ± 0.07 mL/min, 0.70 ± 0.08 mL/min, and 0.13 ± 0.06, respectively. The drug dialyzability in HD rats was similar to reported clinical data except for doripenem. A higher correlation was observed between drug dialyzability in reported clinical data and HD rats which were adjusted for PBR (r2 = 0.936; p < 0.001) compared to unadjusted (r2 = 0.812; p = 0.009). Therefore, we constructed the prediction formula of the drug dialyzability in HD patients by utilizing the HD rat model and PBR. This study is useful for evaluating the dialyzability of high-risk drugs in a clinical setting and might provide appropriate preclinical dialyzability data for new drug.

1 January 2013 in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Verified
Journal Article
Open access
SYSeiichiro Yoshikawa
Seiichiro Yoshikawa
MFMasaki Fukunaga
Masaki Fukunaga
YLYoshifumi Lee
Yoshifumi Lee
KNKunihiko Nagakari
Kunihiko Nagakari
MSMasahiko Sugano
Masahiko Sugano
YHYoshinori Hirasaki
Yoshinori Hirasaki

1 January 2020 in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Verified
Journal Article
Open access
PDF file
SYSeiichiro Yoshikawa
Seiichiro Yoshikawa
YIYoichi Ishizaki
Yoichi Ishizaki
MFMasaki Fukunaga
Masaki Fukunaga
Noriyuki InakiNoriyuki Inaki
Noriyuki Inaki
KNKunihiko Nagakari
Kunihiko Nagakari
AMAkio Mizushima
Akio Mizushima
目的:緩和手術の適応では2カ月以上の予後が期待できることが望ましいとされるが,終末期における予後予測は困難である.緩和手術症例を対象として,予後予測指標であるpalliative prognostic index (PPI),prognostic nutritional index(PNI),modified Glasgow prognostic score(mGPS),controlling nutritional status(CONUT)について,60日予後予測指標としての有用性を検討した. 方法:緩和手術症例94例における各予後予測指標の術後60日生存率予測精度を比較した.各指標についてカットオフ値を設定し,2群に分類して統計学的検討を行った. 結果:PPI,PNI,CONUTは緩和手術後60日生存と有意に相関しており,PPI,PNI,CONUT良好群は,それぞれの不良群との比較において60日生存率が有意に良好であった.予後予測精度はPPIが最も良好であった. 結論:PPI,PNIおよびCONUTは,緩和手術症例において60日生存予測指標となり得ることが示された.

7 April 2014
Verified
Book Chapter
Closed access
PDF file
MFMasaki Fukunaga
Masaki Fukunaga
GKGoutaro Katsuno
Goutaro Katsuno
KNKunihiko Nagakari
Kunihiko Nagakari
SYSeiichiro Yoshikawa
Seiichiro Yoshikawa

1 January 2002 in Progress of Digestive Endoscopy
Verified
Journal Article
Open access
HHHisashi Harada
Hisashi Harada
KOKyoko Okumura
Kyoko Okumura
SIShiho Iwamoto
Shiho Iwamoto
YOYasuo Okada
Yasuo Okada
TSToshiaki Suzuki
Toshiaki Suzuki
FSFujihiko Suzuki
Fujihiko Suzuki